Ignite Creation Date:
2025-12-24 @ 5:17 PM
Ignite Modification Date:
2026-03-02 @ 4:37 PM
Study NCT ID:
NCT06768450
Status:
NOT_YET_RECRUITING
Last Update Posted:
2025-01-16
First Post:
2024-09-13
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Online Meditation for Mild Cognitive Impairment and Mild Dementia
Sponsor:
King's College London
Organization:
Study Overview
Official Title:
Online Mindfulness Meditation for Mild Cognitive Impairment and Mild Dementia: a Feasibility Study
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The study will look at whether online mindfulness meditation (OMM) is easy for older adults with mild cognitive impairment (MCI) and mild dementia to use. It will also see how OMM affects their mood, sleep, and quality of life.
The investigators will recruit 32 participants, divided into 4 groups of 8 people each.
Participants will:
* Attend an online mindfulness meditation class once a week for 8 weeks
* Practice at home for 20 minutes each day
* Keep a simple record of their practice and feelings
The investigators will recruit 32 participants, divided into 4 groups of 8 people each.
Participants will:
* Attend an online mindfulness meditation class once a week for 8 weeks
* Practice at home for 20 minutes each day
* Keep a simple record of their practice and feelings
Detailed Description:
This research aims to investigate the feasibility and acceptability of online meditation for older adults with mild cognitive impairment (MCI) and mild dementia in the UK and to explore its impact on cognitive function, mood, mindfulness, and quality of life. This study will recruit 32 participants with MCI and mild dementia. Participants will receive mindfulness meditation training in an online group-based format, with 8 participants per group in 4 waves. A qualified meditation teacher will lead the sessions via Microsoft Teams once a week for 8 weeks (lasting 2 to 2.5 hours per session).
The study outcomes will include feasibility of the intervention, acceptability to participants, cognitive function, mindfulness, and quality of life. Data will be collected at baseline and after the intervention. A paired t-test will compare pre- and post-intervention changes if the data meet assumptions of normal distribution and homogeneity of variance. Otherwise, non-parametric statistical analyses will be applied.
The study outcomes will include feasibility of the intervention, acceptability to participants, cognitive function, mindfulness, and quality of life. Data will be collected at baseline and after the intervention. A paired t-test will compare pre- and post-intervention changes if the data meet assumptions of normal distribution and homogeneity of variance. Otherwise, non-parametric statistical analyses will be applied.
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
False
Is an FDA AA801 Violation?:
Secondary ID Infos
| Secondary ID | Type | Domain | Link | View |
|---|---|---|---|---|
| 341708 | REGISTRY | The Integrated Research Application System (IRAS) in UK | View |